Back to Market Feed

Product Information

TAFLUPROST 0.0015% EYE DROP is a generic product labeled by Micro Labs Limited, priced at $2.4873 per EA under NDC 42571026473. Its NADAC has been published 183 times since Feb 22, 2023.

FDA first approved this application on Aug 19, 2019. Its Orange Book therapeutic-equivalence code is AT.

TAFLUPROST 0.0015% EYE DROP

tafluprost opthalmic
$2.4873per EA

Strength

.0045 mg/.3mL

Manufacturer

Micro Labs Limited

NDC

42571026473

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

8/19/2026

Active Ingredients

TAFLUPROST

Approval Type

Generic (ANDA)

FDA Application

ANDA209051

FDA Approved

8/19/2019

TE Code

AT

On Market Since

11/18/2022

Pharmacological Classes

Increased Prostaglandin Activity
Prostaglandin Analog
Prostaglandin Receptor Agonists
Prostaglandins

Price Statistics

The NADAC for TAFLUPROST 0.0015% EYE DROP has been published 183 times since Feb 22, 2023, and over the history we have for it it has declined 42.1%. The table below summarizes its recorded NADAC range and movement.

Current price$2.4873 per EA
All-time high$4.7773 (May 10, 2023)
All-time low$2.3815 (Jul 22, 2026)
52-week high$3.1077
52-week low$2.3815
Median price$3.4781
Average price$3.5078
Largest weekly change+36.0% (Jun 19, 2024)
Weeks tracked183
Tracking sinceFeb 22, 2023

Price History

1W

+4.4%

1M

+4.4%

3M

-8.0%

6M

-13.8%

1Y

-20.0%

3Y

-42.3%

5Y

N/A

All

-42.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the tafluprost opthalmic market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

TAFLUPROST 0.0015% EYE DROP
Generic
00781618487•Sandoz Inc.
$2.4873
per EA
TAFLUPROST 0.0015% EYE DROP
Generic
50742033930•Ingenus Pharmaceuticals LLC
$2.4873
per EA
TAFLUPROST 0.0015% EYE DROP
Generic
66993042930•Prasco Laboratories
$2.4873
per EA
BIMATOPROST 0.03% EYE DROPS
Generic
42571012828•Micro Labs Limited
$4.2350
per ML
BIMATOPROST 0.03% EYE DROPS
Generic
65862080210•Aurobindo Pharma Limited
$4.2350
per ML
BIMATOPROST 0.03% EYE DROPS
Generic
70069040301•Somerset Therapeutics, LLC
$4.2350
per ML
BIMATOPROST 0.03% EYE DROPS
Generic
42571012835•Micro Labs Limited
$7.3396
per ML
BIMATOPROST 0.03% EYE DROPS
Generic
60505058304•Apotex Corp.
$7.3396
per ML
BIMATOPROST 0.03% EYE DROPS
Generic
62332050725•Alembic Pharmaceuticals Inc.
$7.3396
per ML
BIMATOPROST 0.03% EYE DROPS
Generic
65862080244•Aurobindo Pharma Limited
$7.3396
per ML

Frequently asked questions

What is the NADAC price of TAFLUPROST 0.0015% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for TAFLUPROST 0.0015% EYE DROP, manufactured by Micro Labs Limited, is $2.4873 per EA (NDC 42571026473), effective Aug 19, 2026.

How has the price of TAFLUPROST 0.0015% EYE DROP changed over time?

Over the history we have for it, the NADAC for TAFLUPROST 0.0015% EYE DROP has declined 42.1%. It has been tracked across 183 weekly CMS publications since Feb 22, 2023.

What are the highest and lowest recorded NADAC prices for TAFLUPROST 0.0015% EYE DROP?

Since Feb 22, 2023, the NADAC for TAFLUPROST 0.0015% EYE DROP has ranged from a low of $2.3815 (Jul 22, 2026) to a high of $4.7773 (May 10, 2023), with a median of $3.4781 per EA.

Are there cheaper alternatives to TAFLUPROST 0.0015% EYE DROP?

No other NADAC-published product currently shares the active ingredient and strength of TAFLUPROST 0.0015% EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures TAFLUPROST 0.0015% EYE DROP?

TAFLUPROST 0.0015% EYE DROP (NDC 42571026473) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.